Number of items: 1.
2019
Al-Batran, S.-E.,
Pauligk, C.,
Hofheinz, R. D.,
Lorenzen, S.,
Wicki, A.,
Siebenhuener, A. R.,
Schenk, M.,
Thuss-Patience, P. C.,
Kretzschmar, A.,
Bolling, C.,
Eigendorff, E.,
Angermeier, S.,
Pink, D.,
Geissler, M.,
Goekkurt, E.,
Schmalenberg, H.,
Waberer, L.,
Talbot, J. J.,
Goetze, T. O. and
Homann, N.
(2019)
Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK.
Annals of Oncology 30 (Suppl5), v324.
Fulltext not available.
This list was generated on Tue Oct 8 01:03:14 2024 CEST.